ClinicalTrials.govpublic full text
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
atopic dermatitis, il-13, aslan004, il-13rα1, eczema, anti-il-13rα1, atopic eczema, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 969605
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.